MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0087703
Indeus Life Sciences Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹8.56 Cr
▲ 283% YoY
Net profit · FY 2023
₹5.58 Lakh
Net margin 0.7%
EBITDA · FY 2023
₹86.69 Lakh
EBITDA margin 10.1%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹20.22 Cr
Issued & subscribed
Company age
19 yrs
Est. 2007
Employees · EPFO
36
Provident fund records
Directors on board
4
As per MCA filings
About Indeus Life Sciences Private Limited
Data last updated:
Indeus Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Genocare Pharma Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2007PTC168501. Its GSTIN is 27AABCI6783L1Z0 (Maharashtra).
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.22 Cr. It was formerly known as Indec Life Sciences Private Limited. It is led by directors including Dharmaraj Karunakar Shetty (Managing Director) and Shantisudha Dharmaraj Shetty.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹8.56 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.58 Lakh (net margin 0.7%) and EBITDA of ₹86.69 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 4% over five years.
The company has about 36 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Indeus Life Sciences. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹20.08 Cr; the latest was in March 2020. The company has 8 MSME Form 1 returns on record between 2019 and 2024, listing 65 overdue payments to 26 micro and small suppliers.
Indeus Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0087703). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indeus.in.
Company details
CIN U24232MH2007PTC168501
Registration Number 168501
Incorporation Date 08 March 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Parent Company Genocare Pharma Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0087703
Key People
Dharmaraj Karunakar Shetty Managing Director Shantisudha Dharmaraj Shetty Director Samir Madhukar Gaikwad Nominee Director Recognitions & Rankings of Indeus Life Sciences
Contact details
Indeus Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is indeus.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSu Motors Complex Ground Floor Bal Rajeshwar Road Model Town Mulund W, Est, Mumbai, Maharashtra, India – 400080
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Indeus Life Sciences Private Limited, buy the company report.
Comprehensive company report
Indeus Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Indeus Life Sciences operates one associated brand: Indeus Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers formulation development, R&D, and manufacturing services for regulated pharmaceutical markets. | indeus.in |
Business activity
The main business activities of Indeus Life Sciences are professional, scientific and technical and manufacturing. In detail, this covers scientific research and development and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indeus Life Sciences Private Limited, buy the company report.
Financials of Indeus Life Sciences Private Limited
FY 2023 filings availableIndeus Life Sciences Private Limited reported revenue of ₹8.56 Cr (up 283% YoY) for FY 2023.
Revenue · FY 2023
₹8.56 Cr ▲ 283%
Net profit · FY 2023
₹5.58 Lakh margin 0.7%
EBITDA · FY 2023
₹86.69 Lakh margin 10.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 283%
3 years · compounded
▲ 15%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 118%
3 years · compounded
▲ 34%
5 years · compounded
▼ 13%
Revenue rose 283% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹86.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indeus Life Sciences Private Limited, buy the company report.
Board of directors of Indeus Life Sciences Private Limited
Indeus Life Sciences has 4 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shantisudha Dharmaraj Shetty Also directs: Genocare Pharma Private Limited | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Samir Madhukar Gaikwad Also directs: Sameeksha Pharmaceuticals Private Limited, Zyrex Healthcare Private Limited, Solean India Private Limited and 3 more | Nominee Director | 07 Apr 2023 | 3 Years 6 Months | Current |
| Dharmaraj Karunakar Shetty Also directs: Genocare Pharma Private Limited | Managing Director | 30 Mar 2020 | 6 Years 6 Months | Current |
| Finny Joseph | Director | 24 Sep 2021 | 5 Years 1 Months | Current |
Auditor
Indeus Life Sciences Private Limited is audited by BHATIA AND POOJARI for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHATIA AND POOJARI | FY 2022 | 141834W |
Shareholding
The shareholding of Indeus Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Indeus Life Sciences Private Limited, buy the company report.
Deals & funding
Indeus Life Sciences Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹20.08 Cr; the latest was in March 2020.
Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹20.08 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Genocare Pharma Private Limited , an individual Seller: Disphar International BV, Nordic Group BV |
| Jun 2014 | Funding round | ₹11.7 Cr | Investors: Nordic Group BV |
| Jan 2009 | Funding round | ₹6.44 Cr | Investors: Nordic Group BV |
| Jun 2008 | Funding round | ₹1.83 Cr | Investors: Nordic Group BV |
| May 2008 | Secondary share transfer | Undisclosed | Buyer: Nordic Group BV, Disphar International BV Seller: 2 individuals |
To see the full deal history of Indeus Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Indeus Life Sciences Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by Hero Fincorp Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed against the company by Aletheia Technologics Pvt Ltd | Disposed |
To see the full case history of Indeus Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Indeus Life Sciences Private Limited has 8 MSME Form 1 returns on record between 2019 and 2024, listing 65 overdue payments to 26 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 26)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Zen Scientific Private Limited | |||
| Vintex Fire Protection Private Limited | |||
| an individual supplier | |||
| Intermax Services Private Limited |
To see the full MSME payment records of Indeus Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Indeus Life Sciences Private Limited has a workforce of 36 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
36
Active EPFO establishments
1
Employee growth
33.33%
GST
Indeus Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCI6783L1Z0 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Indeus Life Sciences Private Limited, buy the company report.
Recent activity
Indeus Life Sciences Private Limited has 17 board changes on record since 2008: 4 appointments and 13 cessations. The latest: Samir Madhukar Gaikwad was appointed as Nominee Director on 07 Apr 2023.
AGM
Indeus Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Appointed
Samir Madhukar Gaikwad was appointed as Nominee Director.
Filing
Indeus Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai I.
Ceased
Finny Joseph ceased to be Additional Director.
Appointed
Finny Joseph was appointed as Director.
Appointed
Shantisudha Dharmaraj Shetty was appointed as Director.
Ceased
Gagan Bhandar ceased to be Additional Director.
Ceased
Cornelis Ter Haar ceased to be Director.
Ceased
Dharmaraj Karunakar Shetty ceased to be Additional Director.
Appointed
Dharmaraj Karunakar Shetty was appointed as Managing Director.
Ceased
Kenneth Stokholm ceased to be Additional Director.
Ceased
Hans Schram ceased to be Director.
8 earlier events are in the company report.
Frequently asked questions
Indeus Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 March 2007 (19+ years old) and is registered under CIN U24232MH2007PTC168501.
Indeus Life Sciences has 4 current directors:
- Dharmaraj Karunakar Shetty - Managing Director
- Shantisudha Dharmaraj Shetty - Director
- Samir Madhukar Gaikwad - Nominee Director
- Finny Joseph - Director
The latest financial statements of Indeus Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Indeus Life Sciences is 27AABCI6783L1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Indeus Life Sciences is U24232MH2007PTC168501. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indeus Life Sciences has 2 court cases on record: 2 filed against it. 1 is pending.
Indeus Life Sciences was incorporated on 08 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Indeus Life Sciences has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹20.08 Cr; the latest was in March 2020.
Samir Madhukar Gaikwad was appointed as Nominee Director on 07 Apr 2023. Finny Joseph ceased to be Additional Director on 22 Nov 2021. Finny Joseph was appointed as Director on 24 Sep 2021. Indeus Life Sciences has 17 board changes on record in total.
Yes, Indeus Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0087703).
Indeus Life Sciences has 8 MSME Form 1 returns on record between 2019 and 2024, listing 65 overdue payments to 26 micro and small suppliers. The latest return was filed on 30 Apr 2024.